A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses

Vaccine
Gayeon WonJohn Hwa Lee

Abstract

Salmonella enterica serovar Typhi ghost was constructed as a vaccine candidate against typhoid fever. An asd+plasmid pJHL187 harboring a ghost cassette comprised of PhiX 174 E lysis gene stringently controlled under the convergent promotor components and was transformed into the asd gene-deleted mutant S. Typhi Ty21a strain (STG). Twenty female BALB/c mice randomly assigned into two groups were subcutaneously vaccinated at 5weeks of age to assess immunogenic characteristics of the constructed STG. The level of serum IgG in the immunized mice was significantly increased during the observational period (P<0.001) as the mice showed the significant elevation of secretory IgA at week 6 compared to those in the non-immunized mice (P<0.05). The CD3+CD4+T cell subpopulation in the primed splenocytes showed approximately twofold increase in the immunized group. Further, the gene expression of various immunomodulatory cytokines associated with Th-1, Th-2 and Th-17 immunity was observed in in vitro restimulated splenocytes isolated from the immunized mice. Serum Bactericidal activity of antibodies produced in the rabbits immunized with STG was proved by the elimination of almost all of wild-type S. Typhi in the presence of exogenous compl...Continue Reading

References

Oct 1, 1970·The New England Journal of Medicine·R B HornickM J Snyder
Jan 26, 1996·Journal of Biotechnology·M P SzostakW Lubitz
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J WainC M Parry
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·V HuterW Lubitz
Sep 23, 2000·Journal of Biotechnology·A G HaslbergerW Lubitz
Feb 13, 2001·Annual Review of Medicine·M E Ohl, S I Miller
Apr 26, 2001·The New England Journal of Medicine·F Y LinS C Szu
Dec 1, 2001·Expert Opinion on Biological Therapy·W Lubitz
Nov 5, 2002·FEMS Microbiology Reviews·Helen S GarmoryRichard W Titball
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Katri JalavaWerner Lubitz
May 30, 2003·The Biochemical Journal·Peter C HeinrichFred Schaper
Dec 21, 2004·Expert Review of Vaccines·Petra WalcherWerner Lubitz
Nov 10, 2005·Vaccine·Carlos A GuzmanGuido Dietrich
Jul 14, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R Leon OchiaiJohn D Clemens
Jan 8, 2008·Current Rheumatology Reports·Erin FitchAndrew Blauvelt
Aug 28, 2009·Clinical and Vaccine Immunology : CVI·Anoop S PulickalAndrew J Pollard
Jan 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lorena Riol-BlancoMohamed Oukka
Feb 18, 2011·Bioengineered Bugs·Timo LangemannWerner Lubitz
Feb 22, 2012·Nature Reviews. Immunology·Onur Boyman, Jonathan Sprent
Apr 12, 2013·TheScientificWorldJournal·Amro A AmaraFars K Alanazi
Feb 6, 2014·Veterinary Microbiology·Chetan V JawaleJohn Hwa Lee
Mar 14, 2014·Clinical and Vaccine Immunology : CVI·Mary Adetinuke BoydMyron M Levine

❮ Previous
Next ❯

Citations

Jun 6, 2020·Expert Review of Vaccines·Ali M Batah, Tarek A Ahmad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.